Katharina M. Droege - Publications

Genetic and environmental risk factors for age-related macular degeneration in persons 90 years and older.

Journal: Investigative ophthalmology & visual science

Published: March 01, 2014

Vascular endothelial growth factor suppression times in patients with diabetic macular oedema treated with ranibizumab.

Journal: The British journal of ophthalmology

Published: November 15, 2013

Retinal layers measurements in healthy eyes and in eyes receiving silicone oil-based endotamponade.

Journal: Acta ophthalmologica

Published: April 06, 2013

Patient preference of ranibizumab treatment regimen for neovascular age-related macular degeneration - monthly injections versus pro re nata.

Journal: Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie

Published: March 13, 2013

Long-term stability of vascular endothelial growth factor suppression time under ranibizumab treatment in age-related macular degeneration.

Journal: American journal of ophthalmology

Published: March 11, 2013

Spectral-domain optical coherence tomography in subjects over 60 years of age, and its implications for designing clinical trials.

Journal: The British journal of ophthalmology

Published: August 07, 2012

Adherence to ranibizumab treatment for neovascular age-related macular degeneration in real life.

Journal: Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie

Published: May 31, 2012

Prevalence of age-related macular degeneration in persons aged 90 years and older in Cologne.

Journal: Acta ophthalmologica

Published: January 25, 2012